Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice
- 18 January 2011
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 26 (8), 2491-2497
- https://doi.org/10.1093/ndt/gfq759
Abstract
Accelerated atherosclerosis and increased cardiovascular events are not only more common in chronic kidney disease (CKD) but are more resistant to therapeutic interventions effective in the general population. The oral charcoal adsorbent, AST-120, currently used to delay start of dialysis, reduces circulating and tissue uremic toxins, which may contribute to vasculopathy, including atherosclerosis. We, therefore, investigated whether AST-120 affects CKD-induced atherosclerosis. Apolipoprotein E-deficient mice, a model of atherosclerosis, underwent uninephrectomy, subtotal nephrectomy or sham operation at 8 weeks of age and were treated with AST-120 after renal ablation. Atherosclerosis and its characteristics were assessed at 25 weeks of age. Uninephrectomy and subtotal nephrectomised mice had significantly increased acceleration of atherosclerosis. AST-120 treatment dramatically reduced the atherosclerotic burden in mice with kidney damage, while there was no beneficial effect in sham-operated mice. The benefit was independent of blood pressure, serum total cholesterol or creatinine clearance. AST-120 significantly decreased necrotic areas and lessened aortic deposition of the uremic toxin indoxyl sulfate without affecting lesional macrophage or collagen content. Furthermore, AST-120 lessened aortic expression of monocyte chemoattractant protein-1, tumor necrosis factor-α and interleukin-1β messenger RNA. AST-120 lessens the extent of atherosclerosis induced by kidney injury and alters lesion characteristics in apolipoprotein E-deficient mice, resulting in plaques with a more stable phenotype with less necrosis and reduced inflammation.This publication has 43 references indexed in Scilit:
- Correlation Between Carotid Intimal/Medial Thickness and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease PatientsClinical Journal of the American Society of Nephrology, 2009
- Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled TrialAmerican Journal of Kidney Diseases, 2009
- Renal Dysfunction Potentiates Foam Cell Formation by Repressing ABCA1Arteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKDAmerican Journal of Kidney Diseases, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisThe New England Journal of Medicine, 2009
- Macrophage deficiency of p38α MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in miceJCI Insight, 2009
- Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stressNephrology Dialysis Transplantation, 2009
- The association of sudden cardiac death with inflammation and other traditional risk factorsKidney International, 2008
- AST-120 Treatment in Pre-Dialysis Period Affects the Prognosis in Patients on HemodialysisRenal Failure, 2008